Skip to content
The Los Angeles

Moderna cancer vaccine cuts melanoma risk in breakthrough trial, shares surge 160%

Moderna cancer vaccine cuts melanoma risk in breakthrough trial, shares surge 160%
Photo: FOX 11 Los Angeles (KTTV) · view original

Moderna and Merck reported promising late-stage trial results for their personalized mRNA cancer vaccine, which lowered the risk of melanoma.

Sources and story details